Influenza hemagglutinin subunit vaccines are more effective and offer better cross protection against various influenza virus ...

Apr. 22, 2025 — A multi-state study reveals that many high-risk adults diagnosed with influenza (flu) in emergency departments and urgent care centers are not receiving timely antiviral treatment.

Influenza virus is an infectious agent belonging to the virus family Orthomyxoviridae that causes a respiratory tract infection (influenza or 'flu') in vertebrates. There are three main species ...

Moderna Inc. said Monday its experimental flu shot showed positive results in a late-stage trial.   In a Phase 3 study, the ...

A CDC panel’s vote to stop recommending thimerosal-containing flu shots would have limited impact, but it illustrates how the ...

The 2024-2025 flu season saw unusually high levels of influenza cases and pediatric deaths, the highest since the 2009-2010 H1N1 pandemic.

The CDC panel voted against an ingredient that the anti-vaccine movement has long targeted, while Arcadia was acquired by ...

Sep. 11, 2024 — Avian influenza A (H5N1) virus, which spread to cattle and infected 14 people this year, was detected using virome sequencing in the wastewater of 10 Texas ...

The multicomponent mRNA-1083 vaccine elicited noninferior immune responses in adult patients when compared with coadministered influenza and COVID-19 vaccines.

Influenza continues to pose a significant global health burden, with seasonal outbreaks causing substantial morbidity and ...

Novavax's experimental COVID-19-influenza combination and standalone influenza vaccines generated a strong immune response in adults aged 65 and older, similar to already approved shots against ...

Novavax, Inc. (Nasdaq: NVAX) today announced results of the initial cohort of its COVID-19-Influenza Combination (CIC) and stand-alone trivalent hemagglutinin nanoparticle seasonal influenza (tNIV ...